Brief: Gracell Biotechnologies Reports First Quarter 2023 Unaudited Financial Results
15/05/2023 12:09
May 15 (Reuters) - Gracell Biotechnologies Inc GRCL.O :
* GRACELL BIOTECHNOLOGIES REPORTS FIRST QUARTER 2023
UNAUDITED
FINANCIAL RESULTS, AND PROVIDES CORPORATE UPDATE
* GRACELL BIOTECHNOLOGIES INC - WELL-FUNDED WITH CASH RUNWAY
TO
END OF 2024
* GRACELL BIOTECHNOLOGIES INC - AS OF MARCH 31, 2023, HAD
US$186.0
MILLION IN CASH AND CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
* GRACELL BIOTECHNOLOGIES INC - QTRLY LOSS PER SHARE $0.07
Source text for Eikon: ID:nGNX1lkYJx
Further company coverage: GRCL.O
Recent news on Gracell Biotechnologies
See all newsBrief: Gracell Biotechnologies Announces Shareholders’ Approval Of Merger Agreement
Brief: Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
Newscasts - UK Day Ahead: European shares start last week of 2023 on strong footing
Live Markets: European futures rise after holiday break
Press Digest: British Business - Dec 27